The West Asia crisis is driving up input costs, freight rates, and export delays for Indian pharma and medical devices, threatening ₹2,500–₹5,000 crore in losses; experts urge government action to strengthen supply chains and diversify markets to Southeast Asia, East Africa and Latin America.


